Hangzhou Tianmu-Shan Pharmaceutical Enterprise Co., Ltd. (600671)
Market Closed
11 Aug, 06:57
SSE SSE Primary ¥
21. 50
-0.2
-0.9217%
¥
1.21B Market Cap
- P/E Ratio
0.66% Div Yield
2.59M Volume
- Eps
¥ 21.7
Previous Close Want to track 600671 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
| Name | Time | Cons. EPS | Eps |
|---|---|---|---|
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
600671 Earnings Reports FAQ
What is the earnings per share (EPS) for 600671?
EPS data for 600671 is currently not available, as Hangzhou Tianmu-Shan Pharmaceutical Enterprise Co., Ltd has not reported recent earnings.
What is the company's earnings growth rate?
Hangzhou Tianmu-Shan Pharmaceutical Enterprise Co., Ltd has not announced its next earnings release date. You can monitor upcoming announcements in Marketlog's earnings calendar or in the company profile.
When is the next earnings release date?
Hangzhou Tianmu-Shan Pharmaceutical Enterprise Co., Ltd has not announced its next earnings release date.
What were the most recent quarterly earnings?
The most recent quarterly earnings for Hangzhou Tianmu-Shan Pharmaceutical Enterprise Co., Ltd are not available at this time.
What is the price-to-earnings (P/E) ratio?
There is no P/E ratio for 600671 at this time, as Hangzhou Tianmu-Shan Pharmaceutical Enterprise Co., Ltd has no recent EPS data to calculate it.
